• Biotin-tyramide: Technical Guidance for Signal Amplification

  2026-05-25

  Biotin-tyramide enables highly sensitive detection in immunohistochemistry (IHC) and in situ hybridization (ISH) via enzyme-mediated signal amplification, especially where conventional biotinylation methods lack the required spatial precision or sensitivity. It is not designed for diagnostic or in vivo applications, and its use is limited to fixed samples in research workflows.

• HRP Rabbit Anti-Goat IgG (H+L) Antibody: Immunodetection Enh

  2026-05-25

  The HRP Rabbit Anti-Goat IgG (H+L) Antibody from APExBIO delivers high-sensitivity, low-background detection of goat primary antibodies across ELISA, western blot, and IHC applications. Its robust HRP conjugation and broad compatibility make it indispensable for studies probing pulmonary toxicity mechanisms, including those triggered by microplastics and nanoplastics.

• Tropifexor (LJN452): Bridging FXR Modulation and Gut-Liver M

  2026-05-24

  Explore how Tropifexor (LJN452) enables advanced modeling of FXR-driven intestinal and hepatic metabolic pathways, uniquely connecting gut barrier research with emerging insights in metabolic regulation. This article delivers a deeper, systems-level analysis of Tropifexor’s applications and scientific context.

• Methotrexate as a Folate Antagonist: Advanced Workflows & As

  2026-05-23

  Methotrexate’s multifaceted mechanism as a folate antagonist enables precise modeling of immunosuppressive and anti-inflammatory pathways in cellular and animal systems. This article distills protocol-level improvements, troubleshooting strategies, and novel applications—guided by high-throughput permeability data—so you can reliably optimize your Methotrexate-based experiments.

• PCI-32765 (Ibrutinib): Transforming B-Cell Malignancy Resear

  2026-05-22

  PCI-32765 (Ibrutinib) stands out as a benchmark BTK inhibitor for dissecting B-cell receptor signaling and modeling chronic lymphocytic leukemia and autoimmune disease. Its nanomolar potency and robust selectivity make it indispensable for advanced disease modeling and translational workflows.

• DOT1L Inhibition Enhances Lenalidomide Responses in Myeloma

  2026-05-22

  This study demonstrates that DOT1L inhibition reprograms innate immunity and significantly potentiates the efficacy of immunomodulatory drugs such as lenalidomide in multiple myeloma models. By elucidating the epigenetic dependencies and mechanistic interplay between DOT1L and interferon signaling, the research provides a novel framework for combination therapy strategies in hematological malignancies.

• Tropifexor (LJN452) in Intestinal Barrier and Liver Disease

  2026-05-21

  Tropifexor (LJN452) is redefining FXR signaling modulation in both intestinal barrier and metabolic disease research. This guide delivers actionable protocols, troubleshooting insights, and data-driven workflow upgrades, bridging bench innovation with translational value.

• IGF2BP1-m6A-THBS1 Axis Drives Macrophage Fibrosis in Lung Di

  2026-05-21

  This study elucidates how the m6A reader IGF2BP1 promotes pulmonary fibrosis by stabilizing THBS1 mRNA, leading to enhanced glycolysis and M2 macrophage polarization via TLR4. These findings reveal a mechanistic link between RNA modifications, macrophage metabolism, and fibrotic disease, with implications for targeted therapeutic strategies.

• ATRX Deficiency Sensitizes Glioma Cells to RTK/PDGFR Inhibit

  2026-05-20

  The referenced study identifies ATRX deficiency as a determinant of heightened sensitivity to receptor tyrosine kinase (RTK) and platelet-derived growth factor receptor (PDGFR) inhibitors in high-grade glioma cells. This finding highlights the potential of ATRX status as a biomarker to guide targeted therapeutic strategies and optimize combinatorial treatments in aggressive gliomas.

• BX795 in Precision Oncology: Integrating Viability Metrics a

  2026-05-20

  Explore how BX795, a potent PDK1 inhibitor, is reshaping cancer research by enabling nuanced analysis of cell viability and immune signaling. This article uniquely bridges mechanistic depth with practical assay strategy, informed by cutting-edge in vitro methodology.

• Entecavir in Decompensated Hepatitis B: Clinical Evidence Re

  2026-05-19

  This review synthesizes data on entecavir's efficacy, safety, and pharmacological profile for managing chronic hepatitis B in patients with decompensated liver disease. It highlights entecavir’s high antiviral potency, low resistance risk, and clinical outcomes compared to other nucleos(t)ide analogues, offering nuanced guidance for both clinical and translational HBV research.

• Nelfinavir Mesylate: Applied Workflows for HIV and Ferroptos

  2026-05-19

  Nelfinavir Mesylate stands out as an HIV-1 protease inhibitor with dual roles in both antiviral and ferroptosis studies. This guide delivers stepwise protocols, real-world troubleshooting, and advanced insights for maximizing assay reliability and translational impact.

• Methylprednisolone Sodium Succinate in Inflammation Research

  2026-05-18

  Methylprednisolone Sodium Succinate empowers researchers to dissect inflammation and immunomodulation with exceptional precision. Its robust anti-inflammatory and apoptosis-inducing properties, combined with high solubility and purity, make it indispensable for advanced cellular assays and translational models.

• Biomimetic Chromatography for Modeling Pulmonary Drug Permea

  2026-05-18

  This study rigorously benchmarks biomimetic chromatographic techniques—specifically IAM-LC and OT-CEC coupled with MS—for modeling lung permeability of small-molecule drugs. The findings provide technical clarity on method robustness, correlation with physicochemical parameters, and practical implications for respiratory drug development and permeability screening.

• Phosphatase Inhibitor Cocktail 1: Precision in Phosphorylati

  2026-05-17

  Discover how Phosphatase Inhibitor Cocktail 1 enables precise protein phosphorylation preservation in challenging tissue contexts. This article uniquely explores its impact on signal pathway integrity and translational assay strategies in light of recent advances in interferon-stimulated gene research.

16047 records 1/1070 page Next 12345 下5页 Last page